NBIX quarterly revenue hits $1 billion on Ingrezza, CRENESSITY growth
Quarterly revenue reached $1 billion, led by strong growth in Ingrezza, CRENESSITY, and VYKAT XR. Ingrezza remains in double-digit growth; CRENESSITY exceeded expectations with robust adoption and persistency.
Quarterly revenue reached $1 billion, driven by strong growth in Ingrezza, CRENESSITY and VYKAT XR. Ingrezza continued double-digit growth with significant market headroom, while CRENESSITY exceeded expectations on robust adoption and persistency. Major pipeline catalysts are expected in 2027—202…